Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Divestments (2023 - 2024)

Roivant Sciences' Divestments history spans 2 years, with the latest figure at $185.6 million for Q4 2024.

  • For Q4 2024, Divestments rose 290.71% year-over-year to $185.6 million; the TTM value through Dec 2025 reached $233.1 million, changed N/A, while the annual FY2025 figure was $260.6 million, 448.6% up from the prior year.
  • Divestments reached $185.6 million in Q4 2024 per ROIV's latest filing, up from $47.5 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $185.6 million in Q4 2024 to a low of $47.5 million in Q4 2023.